Change of Adviser

RNS Number:4314N
Tepnel Life Sciences PLC
11 July 2003



              Tepnel Life Sciences PLC ("Tepnel" or the Company")

         Appointment of Seymour Pierce as Nominated Advisor and Broker

Manchester, UK. 11 July 2003...Tepnel Life Sciences PLC (AIM: TED), the UK-based
international life sciences instrumentation and services company, is pleased to
announce the appointment of Seymour Pierce Limited as the Company's nominated
advisor and broker with immediate effect.

Commenting on this appointment, Ben Matzilevich, Tepnel's CEO, said, "We are
delighted to appoint Seymour Pierce to this role. The organisation is not only
the largest broker to AIM companies but is also developing a strong,
research-led expertise in the life sciences sector, which we believe puts them
in an excellent position to support Tepnel's future growth."

Keith Harris, Chairman of Seymour Pierce, commented, "We firmly believe that the
life science sector offers attractive growth prospects for the right company,
and are therefore very pleased to be able to work with Tepnel to help it fulfil
its ambitions in this sector."

Further enquiries

Tepnel Life Sciences - 0161 946 2200
Ben Matzilevich, CEO
Gron Ffoulkes-Davies, Finance Director

Seymour Pierce - 0207 648 8700
Keith Harris, Chairman
Mark Percy, Director

HCC De Facto Group - 0207 496 3300
David Dible
Mark Swallow

Notes to Editors

Tepnel Life Sciences is a global biotechnology company with a "tripolar"
strategy focused on providing the biomedical industry with high-throughput
automated DNA purification systems, manual DNA purification kits and reagents,
as well as scientific services for nucleic acid purification, drug analysis,
genotyping and genetically modified foods (GMOs).



The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is listed on
the AIM segment of the London Stock Exchange (AIM: TED).



Seymour Pierce is a leading stockbroker specialising in small and medium cap
companies.  Headed by Keith Harris, previously chairman of HSBC Investment Bank,
Seymour Pierce has recently been the subject of a MBO backed by Alchemy
Partners.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

APPGGGMNNGDGFZM